218 related articles for article (PubMed ID: 34668254)
1. Human wildtype tau expression in cholinergic pedunculopontine tegmental neurons is sufficient to produce PSP-like behavioural deficits and neuropathology.
King G; Veros KM; MacLaren DAA; Leigh MPK; Spernyak JA; Clark SD
Eur J Neurosci; 2021 Nov; 54(10):7688-7709. PubMed ID: 34668254
[TBL] [Abstract][Full Text] [Related]
2. Pedunculopontine tegmentum cholinergic loss leads to a progressive decline in motor abilities and neuropathological changes resembling progressive supranuclear palsy.
MacLaren DAA; Ljungberg TL; Griffin ME; Clark SD
Eur J Neurosci; 2018 Dec; 48(12):3477-3497. PubMed ID: 30339310
[TBL] [Abstract][Full Text] [Related]
3. Cre-inducible Adeno Associated Virus-mediated Expression of P301L Mutant Tau Causes Motor Deficits and Neuronal Degeneration in the Substantia Nigra.
You Y; Botros MB; Enoo AAV; Bockmiller A; Herron S; Delpech JC; Ikezu T
Neuroscience; 2019 Dec; 422():65-74. PubMed ID: 31689387
[TBL] [Abstract][Full Text] [Related]
4. Cholinergic neuronal loss in the basal forebrain and mesopontine tegmentum of progressive supranuclear palsy and corticobasal degeneration.
Kasashima S; Oda Y
Acta Neuropathol; 2003 Feb; 105(2):117-24. PubMed ID: 12536222
[TBL] [Abstract][Full Text] [Related]
5. The pedunculopontine nucleus in Parkinson's disease, progressive supranuclear palsy and Alzheimer's disease.
Jellinger K
J Neurol Neurosurg Psychiatry; 1988 Apr; 51(4):540-3. PubMed ID: 3379428
[TBL] [Abstract][Full Text] [Related]
6. Relationship of the extended tau haplotype to tau biochemistry and neuropathology in progressive supranuclear palsy.
Liu WK; Le TV; Adamson J; Baker M; Cookson N; Hardy J; Hutton M; Yen SH; Dickson DW
Ann Neurol; 2001 Oct; 50(4):494-502. PubMed ID: 11601500
[TBL] [Abstract][Full Text] [Related]
7. Characterisation of tau in the human and rodent enteric nervous system under physiological conditions and in tauopathy.
Lionnet A; Wade MA; Corbillé AG; Prigent A; Paillusson S; Tasselli M; Gonzales J; Durieu E; Rolli-Derkinderen M; Coron E; Duchalais E; Neunlist M; Perkinton MS; Hanger DP; Noble W; Derkinderen P
Acta Neuropathol Commun; 2018 Jul; 6(1):65. PubMed ID: 30037345
[TBL] [Abstract][Full Text] [Related]
8. Different tau pathology pattern in two clinical phenotypes of progressive supranuclear palsy.
Jellinger KA
Neurodegener Dis; 2008; 5(6):339-46. PubMed ID: 18349518
[TBL] [Abstract][Full Text] [Related]
9. Pathological, clinical and genetic heterogeneity in progressive supranuclear palsy.
Morris HR; Gibb G; Katzenschlager R; Wood NW; Hanger DP; Strand C; Lashley T; Daniel SE; Lees AJ; Anderton BH; Revesz T
Brain; 2002 May; 125(Pt 5):969-75. PubMed ID: 11960887
[TBL] [Abstract][Full Text] [Related]
10. Cholinergic systems in progressive supranuclear palsy.
Warren NM; Piggott MA; Perry EK; Burn DJ
Brain; 2005 Feb; 128(Pt 2):239-49. PubMed ID: 15649952
[TBL] [Abstract][Full Text] [Related]
11. Progressive supranuclear palsy--parkinsonian disorder with tau pathology.
Kowalska A; Jamrozik Z; Kwieciński H
Folia Neuropathol; 2004; 42(2):119-23. PubMed ID: 15266787
[TBL] [Abstract][Full Text] [Related]
12. Neuropathologic basis of frontotemporal dementia in progressive supranuclear palsy.
Sakae N; Josephs KA; Litvan I; Murray ME; Duara R; Uitti RJ; Wszolek ZK; Graff-Radford NR; Dickson DW
Mov Disord; 2019 Nov; 34(11):1655-1662. PubMed ID: 31433871
[TBL] [Abstract][Full Text] [Related]
13. Disease specificity and pathologic progression of tau pathology in brainstem nuclei of Alzheimer's disease and progressive supranuclear palsy.
Dugger BN; Tu M; Murray ME; Dickson DW
Neurosci Lett; 2011 Mar; 491(2):122-6. PubMed ID: 21236314
[TBL] [Abstract][Full Text] [Related]
14. Sequence analysis of tau in familial and sporadic progressive supranuclear palsy.
Morris HR; Katzenschlager R; Janssen JC; Brown JM; Ozansoy M; Quinn N; Revesz T; Rossor MN; Daniel SE; Wood NW; Lees AJ
J Neurol Neurosurg Psychiatry; 2002 Mar; 72(3):388-90. PubMed ID: 11861703
[TBL] [Abstract][Full Text] [Related]
15. Guadeloupean parkinsonism: a cluster of progressive supranuclear palsy-like tauopathy.
Caparros-Lefebvre D; Sergeant N; Lees A; Camuzat A; Daniel S; Lannuzel A; Brice A; Tolosa E; Delacourte A; Duyckaerts C
Brain; 2002 Apr; 125(Pt 4):801-11. PubMed ID: 11912113
[TBL] [Abstract][Full Text] [Related]
16. Neuropathology of variants of progressive supranuclear palsy.
Dickson DW; Ahmed Z; Algom AA; Tsuboi Y; Josephs KA
Curr Opin Neurol; 2010 Aug; 23(4):394-400. PubMed ID: 20610990
[TBL] [Abstract][Full Text] [Related]
17. Pyramidal system involvement in progressive supranuclear palsy - a clinicopathological correlation.
Stejskalova Z; Rohan Z; Rusina R; Tesar A; Kukal J; Kovacs GG; Bartos A; Matej R
BMC Neurol; 2019 Mar; 19(1):42. PubMed ID: 30894142
[TBL] [Abstract][Full Text] [Related]
18. Increase in the relative expression of tau with four microtubule binding repeat regions in frontotemporal lobar degeneration and progressive supranuclear palsy brains.
Ingelsson M; Ramasamy K; Russ C; Freeman SH; Orne J; Raju S; Matsui T; Growdon JH; Frosch MP; Ghetti B; Brown RH; Irizarry MC; Hyman BT
Acta Neuropathol; 2007 Nov; 114(5):471-9. PubMed ID: 17721707
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of four-repeat tau mRNA isoforms in progressive supranuclear palsy but not in Alzheimer's disease.
Chambers CB; Lee JM; Troncoso JC; Reich S; Muma NA
Ann Neurol; 1999 Sep; 46(3):325-32. PubMed ID: 10482263
[TBL] [Abstract][Full Text] [Related]
20. Pathological tau burden and distribution distinguishes progressive supranuclear palsy-parkinsonism from Richardson's syndrome.
Williams DR; Holton JL; Strand C; Pittman A; de Silva R; Lees AJ; Revesz T
Brain; 2007 Jun; 130(Pt 6):1566-76. PubMed ID: 17525140
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
